Verrica Pharmaceuticals Inc. Proceeds from Stock Options Exercised
Verrica Pharmaceuticals Inc. (VRCA) reported Proceeds from Stock Options Exercised of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-03-11
- Verrica Pharmaceuticals Inc. proceeds from stock options exercised for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Verrica Pharmaceuticals Inc. proceeds from stock options exercised for the quarter ending 2025-09-30 was $0.00.
- Verrica Pharmaceuticals Inc. proceeds from stock options exercised for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Verrica Pharmaceuticals Inc. proceeds from stock options exercised for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Verrica Pharmaceuticals Inc. proceeds from stock options exercised for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Verrica Pharmaceuticals Inc. proceeds from stock options exercised for fiscal 2024 was $155.00K, a 2114.29% increase from fiscal 2023.
- Verrica Pharmaceuticals Inc. proceeds from stock options exercised for fiscal 2023 was $7.00K.
- Verrica Pharmaceuticals Inc. proceeds from stock options exercised for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $0.00 derived: sum of 2 quarters · filed 2026-03-11 | $0.00 derived: sum of 3 quarters · filed 2026-03-11 | $0.00 10-K · filed 2026-03-11 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | $1.00K derived: sum of 4 quarters · filed 2026-03-11 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | $1.00K derived: sum of 3 quarters · filed 2026-03-11 | $1.00K derived: sum of 4 quarters · filed 2026-03-11 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | $1.00K derived: sum of 2 quarters · filed 2026-03-11 | $1.00K derived: sum of 3 quarters · filed 2026-03-11 | $151.00K derived: sum of 4 quarters · filed 2026-03-11 |
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $1.00K derived: sum of 2 quarters · filed 2026-03-11 | $151.00K derived: sum of 3 quarters · filed 2026-03-11 | $155.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $150.00K derived: sum of 2 quarters · filed 2025-11-14 | $154.00K 10-Q · filed 2025-11-14 | $154.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $150.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $154.00K 10-Q · filed 2025-08-12 | $154.00K derived: sum of 3 quarters · filed 2025-08-12 | $154.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $4.00K 10-Q · filed 2025-05-13 | $4.00K derived: sum of 2 quarters · filed 2025-05-13 | $4.00K derived: sum of 3 quarters · filed 2025-05-13 | $4.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $0.00 derived: sum of 2 quarters · filed 2025-03-11 | $0.00 derived: sum of 3 quarters · filed 2025-03-11 | $7.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $0.00 derived: sum of 2 quarters · filed 2024-11-05 | $7.00K 10-Q · filed 2024-11-05 | $7.00K derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $7.00K 10-Q · filed 2024-08-14 | $7.00K derived: sum of 3 quarters · filed 2024-08-14 | $7.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $7.00K 10-Q · filed 2024-05-13 | $7.00K derived: sum of 2 quarters · filed 2024-05-13 | $7.00K derived: sum of 3 quarters · filed 2024-05-13 | $7.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $0.00 derived: sum of 3 quarters · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2023-08-08 | $45.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2023-05-09 | $45.00K derived: sum of 3 quarters · filed 2023-05-09 | $318.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $45.00K derived: sum of 2 quarters · filed 2023-03-06 | $318.00K derived: sum of 3 quarters · filed 2023-03-06 | $558.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $318.00K derived: sum of 2 quarters · filed 2022-11-07 | $558.00K 10-Q · filed 2022-11-07 | $1.00M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $273.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $513.00K 10-Q · filed 2022-08-11 | $959.00K derived: sum of 3 quarters · filed 2022-08-11 | $959.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $240.00K 10-Q · filed 2022-05-09 | $686.00K derived: sum of 2 quarters · filed 2022-05-09 | $686.00K derived: sum of 3 quarters · filed 2022-05-09 | $686.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $446.00K derived: sum of 2 quarters · filed 2022-03-02 | $446.00K derived: sum of 3 quarters · filed 2022-03-02 | $453.00K 10-K · filed 2022-03-02 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $7.00K 10-Q · filed 2021-11-12 | $211.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $7.00K 10-Q · filed 2021-08-10 | $211.00K derived: sum of 3 quarters · filed 2021-08-10 | $215.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $7.00K 10-Q · filed 2021-05-07 | $211.00K derived: sum of 2 quarters · filed 2021-05-07 | $215.00K derived: sum of 3 quarters · filed 2021-05-07 | $427.00K derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $208.00K derived: sum of 2 quarters · filed 2021-03-17 | $420.00K derived: sum of 3 quarters · filed 2021-03-17 | $423.00K 10-K · filed 2021-03-17 |
| 2019-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $216.00K derived: sum of 2 quarters · filed 2020-11-09 | $219.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $212.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $215.00K 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $3.00K 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $7.00K 10-K · filed 2020-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |